The RANTES -403G>A promoter polymorphism in Korean men:: association with serum RANTES concentration and coronary artery disease

In the present Study we investigated the association of the RANTES (regulated upon activation, normal T-cell expressed and secreted) - 28C > G and - 403G > A promoter polymorphisms with the concentration of serum RANTES and CAD (coronary artery disease) in Korean men. We included 553 male CAD patients with (n = 176) or without (n = 377) Type 2 diabetes, aged 4065 years with previous myocardial infarction (similar to 50%) or angiographically confirmed CAD (similar to 50%), and 416 aged-matched healthy male controls. The main outcome measures were the OR (odds ratio) of CAD risk and the serum RANTES concentration evaluated by sandwich ELISA. Although the RANTES - 28C > G genotype had no significant association with CAD risk, the presence of the minor allele of the RANTES - 403G > A single nucleotide polymorphism was associated with a lower risk of CAD {OR 0.70 [95% CI (confidence interval) 0.54-0.92], P = 0.011} after adjusting for age, BMI (body mass index), cigarette smoking and alcohol consumption. Serum RANTES concentrations were significantly associated with the - 403G > A genotype in controls (G/G: 44.7 +/- 3.3 ng/ml, G/A: 36.5 +/- 2.0 ng/ml, A/A: 28.7 +/- 2.5 ng/ml; P < 0.001), non-diabetic CAD patients (G/G: 50.9 +/- 3.0 ng/ml, G/A: 42.2 +/- 2.6 ng/ml, A/A: 41.3 +/- 4.4 ng/ml; P < 0.05) and diabetic CAD patients (G/G: 58.5 +/- 3.5 ng/ml, G/A: 49.6 +/- 4.1 ng/ml, A/A: 42.2 +/- 4.3 ng/ml; P < 0.05); however, such associations were not observed in the subgroup of CAD patients taking lipid-lowering,medication. Moreover, serum RANTES was positively correlated with C-reactive protein (r = 0.289, P < 0.001) and platelet counts (r = 0.253, P < 0.001). The results of the present study demonstrate that the RANTES -403A allele is associated with lower serum RANTES concentrations and consequently with reduced CAD risk.